ISSN: 1449-1907International Journal of Medical Sciences
Global reach, higher impact
Int J Med Sci 2022; 19(10):1502-1509. doi:10.7150/ijms.73947 This issue Cite
Research Paper
Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells
1. Department of Optometry, Asia University, Taichung, Taiwan.
2. Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan.
3. Department of Microbiology and Immunology, School of Medicine, Chung-Shan Medical University, and Clinical Laboratory, Chung Shan Medical University Hospital, Taichung, Taiwan.
4. Department of Nutrition, Chung Shan Medical University and Chung Shan Medical University Hospital, Taichung, Taiwan.
5. Chinese Medicine Department, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
6. Emergency department, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan.
7. Department of Occupational Safety and Health, Chung Shan Medical University, Taiwan; Department of Occupational Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
#These authors contributed equally to this work.
Citation:
Lin HW, Shen TJ, Yang NC, Wang M, Hsieh WC, Chuang CJ, Lai CY, Chang YY. Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells. Int J Med Sci 2022; 19(10):1502-1509. doi:10.7150/ijms.73947. https://www.medsci.org/v19p1502.htm
Other stylesAbstract
Fine particulate matter (PM2.5) is the critical cause of lung cancer and can further promote tumor cell migration and invasion. This study investigated the effects of luteolin, an antiangiogenic flavonoid agent, on blocking aqueous extract PM2.5-prompted cancer progression. We observed that luteolin reduced cell migration and the expression of pro-metastatic factors pro-matrix metalloproteinase (MMP)-2 and intercellular adhesion molecule (ICAM)-1 in PM2.5-exposed H460 lung cancer cells. Luteolin treatment also reduced the transduction of PM2.5-induced epidermal growth factor receptor (EGFR)-phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT) cascade signaling. Furthermore, the reduction of MMP-2 expression and ICAM-1 production by luteolin in PM2.5-stimulated H460 cells is EGFR-PI3K-AKT pathway dependent. These results suggest that luteolin exhibits antitumor progression by inhibiting EGFR-PI3K-AKT pathway.
Keywords: luteolin, PM2.5, lung cancer, metastasis, EGFR-PI3K-AKT signalling
Citation styles
APA
Lin, H.W., Shen, T.J., Yang, N.C., Wang, M., Hsieh, W.C., Chuang, C.J., Lai, C.Y., Chang, Y.Y. (2022). Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells. International Journal of Medical Sciences, 19(10), 1502-1509. https://doi.org/10.7150/ijms.73947.
ACS
Lin, H.W.; Shen, T.J.; Yang, N.C.; Wang, M.; Hsieh, W.C.; Chuang, C.J.; Lai, C.Y.; Chang, Y.Y. Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells. Int. J. Med. Sci. 2022, 19 (10), 1502-1509. DOI: 10.7150/ijms.73947.
NLM
Lin HW, Shen TJ, Yang NC, Wang M, Hsieh WC, Chuang CJ, Lai CY, Chang YY. Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells. Int J Med Sci 2022; 19(10):1502-1509. doi:10.7150/ijms.73947. https://www.medsci.org/v19p1502.htm
CSE
Lin HW, Shen TJ, Yang NC, Wang M, Hsieh WC, Chuang CJ, Lai CY, Chang YY. 2022. Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells. Int J Med Sci. 19(10):1502-1509.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.